CONTACT US   |  (864) 397-5101

MUSC ranks in top 100 in best medical schools for research

The Medical University of South Carolina College of Medicine has been ranked No. 56 in Best Medical Schools: Research by U.S. News & World Report’s latest survey. The school tied with Georgetown University.  

When ranked solely among other public institutions, MUSC came in at No. 30. 

The U.S. News research rankings are based on federal expenditures, survey assessments completed by deans and senior faculty members at peer institutions, and entering class data, MUSC said. The magazine surveyed 192 accredited medical and osteopathic schools in the U.S. for this year’s rankings. 

“This ranking is truly a testament to the dedication of our faculty, their leadership and their desire to make discoveries that can change the lives of patients,” said Lisa Saladin, MUSC executive vice president for Academic Affairs and provost. “Research is at the core of what we do as an academic health sciences center, and we believe it is an important component of medical education. Our faculty, students, trainees and staff are inspired to reach for the impossible every day, which is vitally important in a time where we’re more committed than ever to improving the health of all.” 

MUSC was additionally recognized by U.S. News & World Report as nationally ranked in several adult specialties, including No. 17 in gynecology, No. 14 in ear, nose and throat and No. 39 in cancer. The institution also was ranked No. 6 in most graduates practicing in medically underserved areas.  

In the most recent Best Children’s Hospitals Honor Roll, MUSC also ranked in pediatric specialties, including No. 12 in cardiology and heart surgery, No. 30 in pediatric nephrology, No. 42 in pediatric gastroenterology and gastrointestinal surgery and No. 44 in cancer.  

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.